Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4 CAD | 0.00% | -9.09% | -6.98% |
Apr. 08 | Premier Health of America Inc. Announces Chief Technology Officer Changes | CI |
Feb. 26 | Premier Health of America Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023 | CI |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
- The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.38 for the 2024 fiscal year.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
Ratings chart - Surperformance
Sector: Software
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-6.98% | 16.24M | - | ||
-18.89% | 217B | B | ||
-5.86% | 68.94B | B- | ||
+0.42% | 58.6B | B | ||
-9.66% | 47.05B | A- | ||
+1.13% | 41.06B | C | ||
-1.22% | 36.13B | B | ||
-10.06% | 28.49B | B | ||
+100.75% | 26.32B | - | ||
+5.03% | 22B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- PHA Stock
- Ratings Premier Health of America Inc.